How can genetic screening influence lung cancer treatment?

Genetic screening and molecular evaluation have transformed the treatment of lung cancer by enabling a personalized approach to therapy. By analyzing the human genome and identifying specific genetic mutations within tumor cells, physicians can create a unique molecular profile or "bar code" for a patient's cancer.1

This information is critical for several reasons:

• Targeted Drug Selection: Identifying specific mutations allows doctors to select drugs specifically designed to interfere with the abnormal molecular mechanisms driving that particular tumor's growth. This is a core component of precision medicine, which tailors treatment to an individual's unique genetic characteristics.12
• Companion Diagnostics: These tests are used to predict how a tumor will respond to a specific drug, ensuring that therapies are matched to patients most likely to benefit.1
• Monitoring and Prognosis: Genetic markers and biomarkers help clinicians monitor whether a treatment is working, detect early signs of recurrence, and estimate the aggressiveness of the disease.13

By moving beyond general classifications, genetic screening allows for more rational, effective, and targeted cancer care.1